Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

GERN stock hub

Geron Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

GERNis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

891.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

GERN

In the news

Latest news · GERN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-27.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-5.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All GERN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

220

Groups with data

Currency

USD

Showing 220 of 220 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000886744
Company name	Geron Corporation
Country	United States
Country code	US
Cusip	374163103
Employees	258
Employees Change	29%
Employees Change Percent	12.66
Enterprise value	$674.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1996-06-30
Isin	US3741631036
Last refreshed	2026-05-10
Market cap	$891.7M
Market cap category	Small-Cap
Price	$1.39
Price currency	USD
Rev Per Employee	760,135.66x
Sector	Healthcare
Sic	2834
Symbol	GERN
Website	https://www.geron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-7.55%
EV Sales Forward	2.64x
EV/Sales	3.44x
FCF yield	-14.16%
P/B ratio	3.89x
P/S ratio	4.55x
PS Forward	3.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-17.89%
EBITDA Margin	-17.65%
Gross margin	65.19%
Gross Profit	$127.8M
Gross Profit Growth	160.57%
Gross Profit Growth Q	30.6%
Net Income	$-67.3M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
Pretax Margin	-34.32%
Profit Margin	-34.32%
Profit Per Employee	$-260,880
ROA	-4
Roa5y	-27.85
ROCE	-7.62
ROE	-27.07
Roe5y	-83.54
ROIC	-5.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-6.32%
Cagr15y	-7.46%
Cagr1y	6.11%
Cagr20y	-7.51%
Cagr3y	-20.43%
Cagr5y	0.89%
EPS Growth Quarters	1
EPS Growth Years	3
Revenue Growth	68.64x
Revenue Growth Q	30.89x
Revenue Growth Quarters	9x
Revenue Growth Years	2x
Revenue Growth3 Y	634.96x
Revenue Growth5 Y	257.04x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.36
Assets	$534.1M
Cash	$312.4M
Current Assets	$498.5M
Current Liabilities	$73.6M
Debt	$122.1M
Debt Equity	$0.53
Equity	$229.1M
Interest Coverage	-1.11
Liabilities	$305M
Long Term Assets	$35.6M
Long Term Liabilities	$231.4M
Net Cash	$217M
Net Cash By Market Cap	$24.34
Net Cash Growth	-35%
Net Debt Equity	$-0.95
Tangible Book Value	$229.1M
Tangible Book Value Per Share	$0.36
WACC	9.49

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.78
Inventory Turnover	0.72
Net Working Capital	$113.6M
Quick ratio	4.85
Working Capital	$425M
Working Capital Turnover	$0.46

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.89%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-47.94%
1Y total return	6.11%
200-day SMA	1.4
3Y total return	-49.64%
50-day SMA	1.58
50-day SMA vs 200-day SMA	50over200
5Y total return	4.51%
All Time High	75.88
All Time High Change	-98.17%
All Time High Date	2000-03-03
All Time Low	0.75
All Time Low Change	85.33%
All Time Low Date	2020-03-16
ATR	0.1
Beta	0.68
Beta1y	1.31
Beta2y	1.5
Ch YTD	5.3
High	1.54
High52	2.01
High52 Date	2026-02-19
High52ch	-30.85%
Low	1.38
Low52	1.04
Low52 Date	2025-11-07
Low52ch	33.65%
Ma50ch	-11.91%
Premarket Change Percent	2.74
Premarket Price	$1.5
Premarket Volume	52,049
Price vs 200-day SMA	-0.86%
RSI	37.35
RSI Monthly	40.96
RSI Weekly	46.31
Sharpe ratio	0.36x
Sortino ratio	0.64
Total Return	-0.89%
Tr YTD	5.3
Tr15y	-68.76%
Tr1m	-20.11%
Tr1w	-12.03%
Tr3m	-9.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$2.75
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.02
Earnings Revenue Estimate	50,542,800x
Earnings Revenue Estimate Growth	27.62x
Operating Income	$-35.1M
Operating margin	-17.89
Price target	$2.17
Price Target Change	$56.12
Price Target Change Top	$97.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	503,198,190%
Float Percent	78.44%
Shares Insiders	0.08%
Shares Institutions	55.28%
Shares Out	641,520,974
Shares Qo Q	0.33%
Shares Yo Y	0.89%
Short Float	16.33%
Short Ratio	3.96
Short Shares	12.81

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-150.5M
Average Volume	15,061,645.2x
Bv Per Share	0.36
CAPEX	$-301,000
Ch10y	-47.94
Ch15y	-71.34
Ch1m	-20.11
Ch1w	-12.03
Ch1y	6.11
Ch20y	-80.75
Ch3m	-9.15
Ch3y	-49.64
Ch5y	4.51
Ch6m	29.91
Change	-4.79%
Change From Open	-7.33
Close	1.46
Days Gap	2.74
Depreciation Amortization	477,000
Dollar Volume	17,717,083.2
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$-35.1M
EBITDA	$-34.6M
EPS	$-0.1
F Score	2
FCF	$-126.3M
FCF EV Yield	-18.71x
FCF Per Share	$-0.2
Financing CF	4,436,000
Fiscal Year End	December
Founded	1,990
Investing CF	106,664,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-02
Ma150	1.42
Ma150ch	-2.39%
Ma20	1.58
Ma20ch	-11.75%
Net CF	-14,831,000
Next Earnings Date	2026-08-05
Open	1.5
Optionable	Yes
Position In Range	6.45
Post Close	1.39
Postmarket Change Percent	0.72
Postmarket Price	$1.4
Ppne	2,959,000
Pre Close	1.46
Price Date	2026-05-08
Ptbv Ratio	3.89
Relative Volume	0.85x
Revenue	196,115,000x
SBC By Revenue	12.36x
Share Based Comp	24,237,000
Tr20y	-79.01%
Tr6m	29.91%
Us State	California
Volume	12,746,103
Z Score	-2.04

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does GERN pay a dividend?

Capital-return profile for this ticker.

Performance

GERN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns GERN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.3%

Float: +78.4% of shares outstanding

Insider ownership

+0.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

GERN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

37.3

Neutral momentum band

Price vs 200-day MA

-0.9%

50/200-day relationship not available

Beta (5Y)

0.68

Less volatile than the market

Sharpe ratio

0.36

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About GERN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current GERN stock rating?

Geron Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full GERN analysis?

The full report lives at /stocks/GERN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for GERN?

The latest report frames GERN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the GERN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.